Document is current
Any future updates will be listed below
-
Authors
Pant, Ayush
Medikonda, Ravi
Lim, Michael
- License Information
-
More Information
Article History
Accepted: 7 September 2020
First Online: 3 November 2020
Compliance with Ethical Standards
:
: Ayush Pant and Ravi Medikonda declare that they have no conflict of interest. Michael Lim has received research support from Arbor Pharmaceuticals, Bristol-Myers Squibb, Accuray, DNATrix, Biohaven, and Kyrin-Kyowa; has received compensation for service as a consultant from Bristol-Myers Squibb, Tocagen, and Stryker; and has a patent issued on focused radiation + immunotherapy and a patent pending and licensed on local chemotherapy + immunotherapy.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
